TCL Archive In Brief: Guide Is Late, So RFP Deadline Extended; Real Cancer Mortality Increase Was .7% January 28, 1977
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009